3 Results for "

Edicotinib

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Edicotinib" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-109086
CAS No.: 1142363-52-7
Purity:  98.80%
Synonyms: JNJ-40346527; JNJ-527
Target:  

c-Fms

Edicotinib (JNJ-40346527) is a potent, selective, brain penetrant and orally active colony-stimulating factor-1 receptor (CSF-1R) inhibitor with an IC50 of 3.2 nM. Edicotinib exhibits less inhibitory effects on KIT and FLT3 with IC50 values of 20 nM and 190 nM, respectively . Edicotinib limits microglial expansion and attenuates microglial proliferation and neurodegeneration in mice. Edicotinib has the potential for Alzheimer’s disease and rheumatoid arthritis research .
loading...
    loading...
Cat. No.: HY-109086A
CAS No.: 1559069-92-9
Synonyms: JNJ-40346527 hydrochloride; JNJ-527 hydrochloride
Target:  

c-Fms

Edicotinib hydrochloride is a potent, selective, brain penetrant and orally active?colony-stimulating factor-1 receptor (CSF-1R)?inhibitor with an IC50 of 3.2 nM. Edicotinib hydrochloride exhibits less inhibitory effects on KIT and FLT3 with IC50 values of 20 nM and 190 nM, respectively . Edicotinib hydrochloride limits microglial expansion and attenuates microglial proliferation and neurodegeneration?in mice. Edicotinib hydrochloride has the potential for Alzheimer’s disease and rheumatoid arthritis research .
loading...
    loading...
Cat. No.: HY-109086R
CAS No.: 1142363-52-7
Synonyms: JNJ-40346527 (Standard); JNJ-527 (Standard)
Edicotinib (Standard) is the analytical standard of Edicotinib (HY-109086). This product is intended for research and analytical applications. Edicotinib (JNJ-40346527) is a potent, selective, brain penetrant and orally active colony-stimulating factor-1 receptor (CSF-1R) inhibitor with an IC50 of 3.2 nM. Edicotinib exhibits less inhibitory effects on KiT and FLT3 with IC50 values of 20 nM and 190 nM, respectively . Edicotinib limits microglial expansion and attenuates microglial proliferation and neurodegeneration in mice. Edicotinib has the potential for Alzheimer’s disease and rheumatoid arthritis research .
loading...
    loading...